Inaktiver Wert

Andere Sprachen Viralytics Ltd.

Aktien

VLA

AU000000VLA6

VLA

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Amgen : Merck to buy virus-based cancer drug firm Viralytics for $394 million	21.02.18
Immunothérapie: Merck & Co achète l'australien Viralytics	21.02.18
Viralytics : Chairman’s letter to shareholders	28.11.17
Viralytics : New Data Presented at SITC Annual Meeting	12.11.17
Viralytics : Annual Report and Full Year Financial Results	18.08.17
Viralytics : Newsletter	28.06.17
Viralytics : Positive Bio-Marker Data from CANON Study	28.06.17
Viralytics : Update on MITCI and KEYNOTE 200 trials at ASCO Ann Meeting	06.06.17
Viralytics : Progress in the CAVATAK® and KEYTRUDA® Combination KEYNOTE-200 clinical trial	05.04.17
Viralytics : CAVATAK® in Combination with YERVOY® Provides Promising Results in Advanced Melanoma from the Phase 1b MITCI clinical study	05.04.17
Viralytics : Promising Results in CAPRA Trial of CAVATAK® in Combination with KEYTRUDA® in Melanoma Patients	04.04.17
Viralytics : Edison Report – Cavatak combo data at AACR next month	09.03.17
Viralytics : ASX Release – Viralytics to Present New CAVATAK Clinical Data at American Association for Cancer Research Annual Meeting 2017	02.03.17
Viralytics : Receives $4.3 Million R&D Tax Incentive	16.02.17
Viralytics : Promising Advanced Melanoma Results from KEYTRUDA Combination Trial announced at SITC	14.11.16
Viralytics : Dr Malcolm McColl on ABC TV's The Business	06.06.16
Edison: Eye-catching MITCI Data	10.05.16
Viralytics : Further Promising Data at AACR Meeting	21.04.16
Viralytics : Clinical Results at Two Major Conferences	17.03.16
Viralytics : Bioshares Top Six Stock Picks for 2016	21.12.15

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Viralytics Ltd.

Aktien

VLA

AU000000VLA6

VLA

Andere Sprachen

Filter